P/E ratio for Titan Medical (TMD.TO)
P/E ratio as of April 2025 (TTM): -0.1126
According to Titan Medical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.112618. At the end of 2022 the company had a P/E ratio of -1.79.
P/E ratio history for Titan Medical from 2008 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -1.79 | -60.05% |
| 2021 | -4.47 | -0.73% |
| 2020 | -4.50 | 1158.76% |
| 2019 | -0.3577 | -60.17% |
| 2018 | -0.8981 | -55% |
| 2017 | -2.00 | 32.35% |
| 2016 | -1.51 | -24.53% |
| 2015 | -2.00 | -73.31% |
| 2014 | -7.49 | 25.41% |
| 2013 | -5.97 | -18.38% |
| 2012 | -7.31 | 111.11% |
| 2011 | -3.46 | -70.88% |
| 2010 | -11.9 | -24.65% |
| 2009 | -15.8 | 793.31% |
| 2008 | -1.77 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.